体外循环中肝素涂层管道应用的进展

n of two heparin-coa ted extracorporeal circuits with reduced systemic anticoagulation in ro utine coronary artery bypass operations［J］. J Thorac Cardiovasc Surg 2001 Feb;121(2):324-330. ［7］Shigemitsu O , Hadama T, Takasaki H, et al. Biocompatibility of a heparin-bonded membrane oxygentor (Carmeda MAXIMA)during the first 90 m inutes of cardiopulmonary bypass: clinical comparison with the conventi onal system［J］. Artif Organs, 1994, 18L 936-941. ［8］Khuri SF, Valeri CR, Loscalzo J, et al. Heparin causes platelet dy sfunction and induces fibrinolysis before cardiopulmonary bypass［J］. Ann Thorac Surg, 1995, 60: 1008-1014. ［9］Cavarocchi NC, Schaff HV, Orszulak TA, et al. Evidence for complem ent activation by heparin-protamin interaction after CPB. Surgery, 198 5, 98:525-531. ［10］Korn RL, Fisher CA, Livingston ER, et al. The effects of CBAS on human blood components during simulated extracorporeal circulation［J］ . J Thorac Cardiovasc Surg 1996,111:1073-1084. ［11］Pekna M, Hagman L, Helden E, et al. Complement activation during CPB:effects of immobilized heparin［J］. Ann Thorac Surg 1994,58:421-4 24. ［12］qvrum E, Mollnes TE, Fosse E, et al. High and low heparin dose w ith heparin-coated CPB: activation of complement and granulocyte［J］. Ann Thorac Surg 1995,60:1755-1761. ［13］Fosse E, Moen O, Johnson E, et al Reduced complement and granuloc yte activation with heparin-coated CPB［J］. Ann Thorac Surg 1994,58: 472-477. ［14］qvrum E, Brosstad F, Holen EA, et al. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and hepa rin-coated CPB. Circulation. 1995,92:2579-2584. ［15］Alder GS, Doursounian M, Gara PO, et al. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG:a prospective , randomized study［J］. Ann Thorac Surg 1996,62:410-418. ［16］Seggesser LK, Weiss BM, Pasic M, et al. Risk and benefit of low s ystemic heparinization during open heart operations［J］. Ann Thorac S urg 1994;58:391-398 ［17］Von Seggesser LK, Weiss BM, Garcia E, et al. Reduced blood loss a nd transfusion requirements with low systemic heparinization: prelimina ry clinical results in coronary artery revascularization［J］. Eur J C ardio-Thorac Surg 1990, 4:639-643. ［18］qvrum E, Holen EA, Tangen G, et al. Completely heparinized CPB an d reduced systemic heparin :clinical and hemostatic effects［J］. Ann Thorac Surg 1995;60:365-371. ［19］Videm V, Svennevig JL, Fosse E, et al. Reduced complement activat ion with heparin-coated oxygenator and tubing in coronary bypass operat ion［J］. J Thorac Cardiovasc Surg 1992,103:806-813. ［20］Dowling RD, Brown ME, Whattington RO, et al. Clinical CPB without systemic anticoagulation［J］. Ann Thorac Surg 1993,56:1176-1178. 21］Bennett J, Hill J, Parsons J, et al. Heparin-free cardiopulmonary s upport utilizing a cameda coated circuit for a patient with pulmonary h emorrhage and multiple trauma［J］. AMSECT 29th International Conferenc e, San Francisco, California, 1991, Mar. 1-4: 15. ［22］Von Segess

《体外循环中肝素涂层管道应用的进展(第3页)》